Related Experiment Video
Updated: Jun 19, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
ATX-LPA receptor axis in inflammation and cancer
Shuying Liu1, Mandi Murph, Nattapon Panupinthu
1Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Abstract:
Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) mediates a plethora of physiological and pathological activities via interactions with a series of high affinity G protein-coupled receptors (GPCR). Both LPA receptor family members and autotaxin (ATX/LysoPLD), the primary LPA-producing enzyme, are aberrantly expressed in many human breast cancers and several other cancer lineages. Using transgenic mice expressing either an LPA receptor or ATX, we recently demonstrated that the ATX-LPA receptor axis plays a causal role in breast tumorigenesis and cancer-related inflammation, further validating the ATX-LPA receptor axis as a rich therapeutic target in cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
lncRNA - Long Non-coding RNAs
Acute Inflammation II: Cellular Phase
The Tumor Microenvironment
Acute Inflammation III: Local and Systemic Effects
